Results 71 to 80 of about 21,197 (216)

Parathyroid Hormone Sampling From the Anterior Jugular Vein Versus Peripheral Vein After Total Thyroidectomy

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, Volume 12, Issue 2, Page 195-201, April 2026.
ABSTRACT Background To determine if anterior jugular vein sampling (AJVS) is non‐inferior to peripheral venous sampling (PVS) for measuring intraoperative parathyroid hormone (PTH) levels following total thyroidectomy. Methods This was a prospective non‐inferiority trial conducted at a tertiary academic medical center.
Noel M. Phan   +4 more
wiley   +1 more source

Giant Parathyroid Tumor: Parathyroid Adenoma versus Parathyroid Carcinoma

open access: yesCase Reports in Endocrinology, 2022
Parathyroid adenoma is the most common cause of primary hyperparathyroidism (PHPT). We present the preoperative detection of a giant parathyroid adenoma (GPA) using (99mTc)-sestamibi parathyroid scintigraphy in a patient presenting with severely elevated
Farid Gossili   +3 more
doaj   +1 more source

Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia [PDF]

open access: yes, 2020
To evaluate safety and efficacy of one- vs. two-session radiofrequency ablation (RFA) of parathyroid hyperplasia for patients with secondary hyperparathyroidism (SHPT) and to compare the outcome of both methods on hypocalcemia.
He, Hong-Feng   +7 more
core   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

open access: yes
World Journal of Surgery, EarlyView.
Matilda Anneback   +5 more
wiley   +1 more source

Clinical Practice Patterns in Bone Health Assessment and Management in Endogenous Cushing's Syndrome

open access: yesClinical Endocrinology, Volume 104, Issue 4, Page 302-311, April 2026.
ABSTRACT Objective Skeletal fragility is a common complication of endogenous Cushing's Syndrome (CS), although specific guidelines for managing bone health are lacking. This study aimed to assess clinicians' current engagement with bone health assessment and management in patients with endogenous CS. Design Retrospective‐cohort design. Patients Seventy‐
Preeshila Behary   +10 more
wiley   +1 more source

Evaluation of Causes of High Parathyroid Hormone Levels in Elderly

open access: yesEndocrinology Research and Practice, 2018
Primary hyperparathyroidism (PHPT) predominantly affects the elderly, with a peak incidence between ages 55 and 70. Parathyroid adenoma is the principal cause, representing 80-85% of all cases.
Pelin Tütüncüoğlu, Fulden Saraç
doaj   +1 more source

Report of the Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) on nutritional risks for women during menopause, perimenopause and postmenopause

open access: yesFood Risk Assess Europe, Volume 4, Issue 2, April 2026.
Abstract Menopause is the time when a woman transitions from the reproductive stage of life to the non‐reproductive state. It is characterised by significant hormonal changes, which can affect a woman's physical, emotional, mental and social well‐being.
Irene Bretón Lesmes   +7 more
wiley   +1 more source

Preoperative 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: Comparison of SPECT-CT, SPECT, and planar imaging

open access: yes, 2012
Background: Investigations using a hybrid single photon emission computed tomography/computed tomography (SPECT-CT) scanning technique have been carried out in limited studies and have shown mixed results.
Assadi, M.   +10 more
core   +1 more source

Multiple endocrine neoplasia [PDF]

open access: yes, 2017
Multiple endocrine neoplasia (MEN) describes the occurrence of tumours affecting two or more endocrine glands in one patient. Two main forms are recognized: MEN type 1 (MEN1) and type 2 (MEN2).
Newey, Paul J.
core   +2 more sources

Pattern and Clinical Significance of CA19‐9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Carbohydrate antigen 19–9 (CA19‐9) is a cell surface glycoprotein widely used as a diagnostic and prognostic serum marker for monitoring pancreatic cancer. The aim of this study was to evaluate the prevalence and clinical relevance of CA19‐9 expression in human cancer. Methods To comprehensively determine the prevalence and clinical
Nina Schraps   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy